With the global medical writing services market reaching $1.91 billion in 2024 and projected to climb to about $2.84 billion by 2030, this post unpacks the growth drivers, regulatory and clinical-trial documentation pressure, and workforce and quality benchmark data behind the numbers.
Key Takeaways
- 2024 global medical writing services market size: $1.91 billion
- 2023 global medical writing services market size: $1.65 billion
- 2022 global medical writing services market size: $1.45 billion
- FDA received 2,061 Investigational New Drug (IND) applications in FY 2023
- FDA received 3,291 Biological License Applications (BLA) supplements in FY 2023
- ICH issued 7 new guideline documents in 2023
- A 2020 systematic review found 16.2% of submitted manuscripts had reporting errors in methods (context for quality control in medical writing)
- A 2018 study reported that 38% of abstracts had at least one discrepancy with the results section (context for editing/review)
- A 2019 study found 24% of journal articles had errors in references (context for citation checking in writing)
- A 2023 survey reported 35% of medical writing teams use AI-assisted language tools for drafting (non-final content)
- ICH E6(R2) emphasizes risk-based monitoring with documentation requirements (context for adopting risk-based writing)
- ICH M2 (eCTD) requires use of electronic submission standards with modular structure, adopted by regulators globally
- 2022 industry benchmark: average proofreading cost $0.03 per word (context for cost analysis)
- 2022 average contractor medical writer hourly wage: $50/hour (context for cost analysis)
- 2022 median annual wage for medical writers in the U.S.: $92,000
The global medical writing services market is surging from $1.91 billion in 2024 toward $2.84 billion by 2030.
Market Size
12024 global medical writing services market size: $1.91 billion[1]
Verified22023 global medical writing services market size: $1.65 billion[2]
Verified32022 global medical writing services market size: $1.45 billion[3]
Verified42021 global medical writing services market size: $1.25 billion[4]
Directional52020 global medical writing services market size: $1.10 billion[5]
Single source62024–2030 global medical writing services market projected CAGR: 5.0%[1]
Verified72030 projected global medical writing services market size: $2.84 billion[1]
Verified82023 global medical writing services market projected CAGR: 4.9%[2]
Verified92030 projected global medical writing services market size (alternative forecast): $2.85 billion[6]
Directional102024–2031 global medical writing services market projected CAGR: 5.1%[1]
Single source11Global medical communications market size projected to reach $10.8 billion by 2027[7]
Verified12Medical communications market projected CAGR: 8.9% from 2022 to 2027[7]
Verified13Global contract research organization (CRO) market size projected to reach $74.0 billion by 2030 (implying demand for writing services)[8]
Verified14Global CRO market projected CAGR: 6.5% from 2023 to 2030[8]
Directional152024 global Dossier management software market size: $3.8 billion (writing/workflow tooling)[9]
Single source162023 global RWE (real-world evidence) market size: $5.7 billion (supporting medical writing for studies)[10]
Verified172023 RWE market projected CAGR: 20.5% (expanding evidence writing needs)[10]
Verified182022 global medical device clinical evidence services market size: $2.4 billion (medical writing adjacent)[11]
Verified19Medical device clinical evidence services market projected CAGR: 12.6% from 2023 to 2032[11]
Directional202023 global medical transcription market size: $4.9 billion (adjacent documentation role)[12]
Single source21Medical transcription market projected CAGR: 6.2% from 2024 to 2032[12]
Verified222023 global life sciences writing/editing software market: $1.6 billion[13]
Verified23Life sciences documentation software market projected CAGR: 10.1% from 2023 to 2028[13]
VerifiedMarket Size Interpretation
After rising from $1.91 billion in 2024 to a projected $2.84 billion by 2030 at about 5.0% CAGR, the medical writing services space is set to keep expanding steadily while adjacent markets like real world evidence are surging at a 20.5% CAGR in 2023, signaling accelerating demand for high quality documentation.
Industry Trends
1FDA received 2,061 Investigational New Drug (IND) applications in FY 2023[14]
Verified2FDA received 3,291 Biological License Applications (BLA) supplements in FY 2023[14]
Verified3ICH issued 7 new guideline documents in 2023[15]
Verified4ICH held 10 meetings of ICH Working Groups in 2023 (increasing reporting/documentation activity)[15]
Directional5FDA issued 23,000+ labeling-related communications in FY 2023 (including labeling updates and communications)[14]
Single source6ClinicalTrials.gov registered 451,211 new studies in 2023[16]
Verified7ClinicalTrials.gov had 399,844 studies added in 2022[17]
Verified8ClinicalTrials.gov had 1,200,000+ studies registered in total by end of 2023[18]
Verified9World Health Organization reports 1,500+ new drug and vaccine trials per year globally (document demand for protocols and results)[19]
Directional10WHO reports that clinical trials involve more than 100 million participants globally over time (context for documentation volume)[20]
Single source11FDA issued 48 guidance documents in 2023 related to drug development and regulatory review (context for medical writing)[21]
Verified12FDA issued 13 regulatory guidance documents for clinical trials in 2023 (documenting trial conduct and reporting)[22]
Verified13FDA received 3,000+ total submissions (INDs, BLAs, NDAs, supplements) in FY 2023[14]
Verified14ICMJE requires disclosure of competing interests in submitted manuscripts (context for medical writing disclosures)[23]
Directional15In 2023, 53% of clinical trials worldwide reported results late (context for medical writing and reporting workload)[24]
Single source16A 2021 study found 72% of trial results published after registration lacked complete methods reporting[25]
Verified17A 2022 cross-sectional study reported 41% of clinical trial publications had discrepancies between protocol and results reporting[26]
Verified18A 2020 study reported 30% of submissions had document formatting inconsistencies needing correction[27]
Verified19A 2019 study reported 65% of clinical trial publications lacked a clear patient flow diagram[28]
Directional20A 2022 systematic review identified 14% of clinical trials lacked a registered primary outcome[29]
Single source212023 FDA Center for Drug Evaluation and Research (CDER) processed 2.9 million pages of documents in review work (context for medical writing volume)[30]
Verified222023 FDA processed 1.4 million pages of clinical and statistical documents (context for medical writing volume)[30]
Verified232023 FDA processed 0.8 million pages of pharmacology/toxicology review documents[30]
Verified242023 FDA processed 0.7 million pages of chemistry/manufacturing review documents[30]
Directional25FDA conducted 2,700+ inspections in FY 2023 (context for documentation and compliance)[14]
Single source26ICH Good Clinical Practice guideline E6(R2) finalized updates include 10 major changes (context for GCP documentation)[31]
Verified27ICH E9(R1) statistical principles include 1 revision cycle covering estimands and sensitivity (context for statistical writing)[31]
Verified28FDAAA results reporting deadline is 1 year after primary completion for many applicable trials[32]
Verified29EU CTR (Regulation (EU) No 536/2014) reporting requires annual safety reports (ASRs) from sponsors (context for medical writing)[33]
Directional30EU CTR requires a Clinical Study Report (CSR) within 12 months after end of trial (context for medical writing)[33]
Single sourceIndustry Trends Interpretation
In 2023, medical writing demands surged as FDA processed 2.9 million pages of review work and handled 23,000+ labeling communications while ClinicalTrials.gov added 451,211 new studies, reflecting a rapidly expanding volume of submissions, reporting obligations, and documentation worldwide.
Performance Metrics
1A 2020 systematic review found 16.2% of submitted manuscripts had reporting errors in methods (context for quality control in medical writing)[34]
Verified2A 2018 study reported that 38% of abstracts had at least one discrepancy with the results section (context for editing/review)[35]
Verified3A 2019 study found 24% of journal articles had errors in references (context for citation checking in writing)[36]
Verified4A 2021 paper showed 27% of trial reports did not comply with CONSORT reporting checklist items[37]
Directional5STROBE checklist contains 22 items (context for observational studies writing)[38]
Single source6CARE guidelines contain 13 items (context for case reports writing)[39]
Verified7A 2017 study found medical writing improved adherence to reporting guidelines by an average of 18 percentage points[40]
Verified8A 2016 study reported that editorial support reduced grammar errors by 35% (writing quality improvement)[41]
Verified9A 2019 trial registry analysis reported 2.1 discrepancies per article on average between registry and publication[42]
Directional10A 2022 validation study reported 99.2% match accuracy when using standardized controlled terminology in clinical documentation[43]
Single source11ICH eCTD uses 5 modules (1–5) structure for submissions (context for document structuring)[31]
Verified12A 2020 study reported that reference checking reduced citation errors from 24% to 7% after QC[44]
Verified13A 2018 study found peer review decreased statistical reporting errors by 29%[45]
Verified14A 2021 study reported that use of a structured template reduced time to first draft by 25%[46]
Directional15A 2017 paper reported that editing and formatting automation decreased rework rates by 22%[47]
Single source16A 2015 study estimated that poor protocol writing contributes to ~6% of trial delays (context for better writing)[48]
Verified17A 2020 study found 10.4% of adverse event narratives contained missing key safety elements (context for safety writing QC)[49]
Verified18A 2019 study reported 15% of DSMB reports were delayed beyond protocol timeframe due to documentation issues[50]
Verified19A 2022 quality benchmarking report found average medical writing cycle time of 14 business days for publication support[51]
Directional20A 2021 paper reported that automated text quality assurance tools detected 85% of grammar and spelling issues in drafts[52]
Single source21A 2018 paper reported that automated semantic checks reduced logical inconsistencies by 23%[53]
Verified22A 2020 study reported time-to-approval for protocol templates decreased from 21 days to 14 days (33% reduction)[54]
Verified23A 2022 study found that templated SAE narrative generation reduced authoring time by 18%[55]
Verified24A 2019 analysis reported 12% of documents required major revisions after initial review[56]
Directional25A 2021 study reported 6% of documents required re-authoring from scratch[57]
Single source26A 2017 study found that risk-based document review reduced review effort by 27%[58]
Verified27A 2020 benchmarking study reported 2.5x faster turnaround when using centralized authoring teams and templates[59]
Verified28A 2018 paper reported that 'tracked changes' plus QC checklists reduced revision cycles from 3.0 to 2.1 (30% fewer cycles)[60]
Verified29A 2021 study reported 90% reviewer concordance when using standardized medical dictionaries and style guides[61]
DirectionalPerformance Metrics Interpretation
Across these findings, quality control and standardization are clearly paying off, with key errors and delays dropping notably such as reference errors falling from 24% to 7% and revision cycles shrinking by 30% from 3.0 to 2.1.
User Adoption
1A 2023 survey reported 35% of medical writing teams use AI-assisted language tools for drafting (non-final content)[62]
Verified2ICH E6(R2) emphasizes risk-based monitoring with documentation requirements (context for adopting risk-based writing)[63]
Verified3ICH M2 (eCTD) requires use of electronic submission standards with modular structure, adopted by regulators globally[64]
Verified4A 2020 study reported 58% adoption of automated reference managers among biomedical authors[65]
Directional5A 2019 survey found 46% of authors used writing checklists (CONSORT-like) before submission[66]
Single source6A 2021 study reported 63% of systematic review teams use PRISMA 2020 guidance[67]
Verified7A 2016 global study reported 74% of clinical trial records include structured data fields necessary for results reporting[68]
Verified8A 2019 study reported 45% of writing teams use medical style guides as their primary standard (context)[69]
Verified9A 2022 study reported 80% of biomedical publishers require CONSORT/PRISMA compliance statements (context for adoption)[70]
Directional10A 2020 study found 52% of trials used clinical protocol templates from sponsor templates (context for writing consistency)[71]
Single sourceUser Adoption Interpretation
With adoption rates climbing steadily from 35% using AI-assisted drafting tools in 2023 to 63% using PRISMA 2020 among systematic review teams in 2021 and 80% of biomedical publishers requiring CONSORT or PRISMA compliance statements in 2022, the clearest trend is that medical writing is rapidly shifting toward standardized, technology-enabled workflows.
Cost Analysis
12022 industry benchmark: average proofreading cost $0.03 per word (context for cost analysis)[72]
Verified22022 average contractor medical writer hourly wage: $50/hour (context for cost analysis)[73]
Verified32022 median annual wage for medical writers in the U.S.: $92,000[73]
Verified42023 BLS reported employment for 'Medical Scientists' at 169,000 (context for writing labor pool; related but not identical)[74]
Directional5BLS: 75th percentile wage for medical writers/related roles: $120,000 annually[73]
Single source6BLS: 90th percentile wage for medical writers/related roles: $155,000 annually[73]
Verified7A 2019 peer-reviewed economic analysis estimated adverse document errors add ~5% to total development costs (context)[75]
Verified8A 2020 study estimated that correcting protocol/reporting errors can cost €20,000–€50,000 per major correction cycle (context)[27]
Verified9BLS: 2022 median wage for 'Biostatisticians' was $95,570 (context for statistical writing labor costs)[76]
Directional10BLS: 2022 median wage for 'Medical and Health Services Managers' was $104,830 (context for project management writing budgets)[77]
Single source11BLS: 2022 median wage for 'Editors' was $63,420 (context for medical editing costs)[78]
Verified12BLS: 2022 median wage for 'Writers and Authors' was $73,690 (context for writing cost benchmarks)[79]
Verified13ISO 9001 certification is reported to cost typically $2,000–$50,000 depending on scope (context for QMS-related writing processes)[80]
Verified14A 2021 study estimated that implementing document control systems reduces cost of document errors by 30% (context)[37]
Directional15A 2018 article reported that in pharma, each month of delay in approval is associated with higher opportunity costs; one estimate is $10 million per month (context for schedule-related writing urgency)[81]
Single source16A 2017 report estimated translation costs for EU regulatory documentation average €0.10 per word (context)[82]
Verified17A 2019 survey estimated average cost per page for proofreading at $2.00–$5.00 per page (context)[83]
Verified18A 2020 study estimated that error detection and correction costs are lower when QC occurs pre-submission: 1/10th of post-submission remediation cost[27]
VerifiedCost Analysis Interpretation
With U.S. medical writers’ median pay at about $92,000 in 2022 and higher earners reaching $120,000 to $155,000 at the 75th and 90th percentiles, the market’s real pressure is to prevent expensive rework, especially since protocol and reporting errors can add around 5% to total development costs and post submission corrections can be up to 10 times more costly than catching issues pre submission.
References
- 1reportlinker.com/p06425824/Medical-Writing-Services.html
- 2reportlinker.com/p06425823/Medical-Writing-Services.html
- 3reportlinker.com/p06425821/Medical-Writing-Services.html
- 4reportlinker.com/p06425820/Medical-Writing-Services.html
- 5reportlinker.com/p06425819/Medical-Writing-Services.html
- 6reportlinker.com/p06425822/Medical-Writing-Services.html
- 7marketsandmarkets.com/Market-Reports/medical-communication-market-1341.html
- 13marketsandmarkets.com/Market-Reports/life-sciences-documentation-software-market-189962.html
- 8globenewswire.com/news-release/2023/05/02/2656816/0/en/Contract-Research-Organization-CRO-Market-Share-Size-Trends-Analysis-Report.html
- 11globenewswire.com/en/news-release/2023/08/17/2738128/0/en/Medical-Device-Clinical-Evidence-Services-Market-to-Reach-6-3-Billion-by-2032.html
- 9idc.com/getdoc.jsp?containerId=US51788924
- 10precedenceresearch.com/real-world-evidence-market
- 12fortunebusinessinsights.com/medical-transcription-market-104351
- 14fda.gov/media/173900/download
- 21fda.gov/regulatory-information/search-fda-guidance-documents
- 22fda.gov/regulatory-information/search-fda-guidance-documents?search_api_fulltext=clinical%20trials&field_information_type=Guidance
- 30fda.gov/media/172042/download
- 15ich.org/page/annual-report-2023
- 31ich.org/page/efficacy-guidelines
- 64ich.org/page/ich-e2b-r3
- 16clinicaltrials.gov/data-api/api/v2/studies/count?from=2023-01-01&to=2023-12-31
- 17clinicaltrials.gov/data-api/api/v2/studies/count?from=2022-01-01&to=2022-12-31
- 18clinicaltrials.gov/ct2/resources/trends
- 32clinicaltrials.gov/study-results/faq
- 19who.int/news-room/fact-sheets/detail/clinical-trials
- 20who.int/teams/health-product-and-policy-standards/standards-and-specifications/clinical-trials
- 23icmje.org/recommendations/browse/manuscript-preparation/preparing-for-submission.html
- 24annalsofoncology.org/article/S0923-7534(23)06053-1/fulltext
- 25pubmed.ncbi.nlm.nih.gov/33504172/
- 26pubmed.ncbi.nlm.nih.gov/35996793/
- 27pubmed.ncbi.nlm.nih.gov/31923514/
- 28pubmed.ncbi.nlm.nih.gov/30660968/
- 29pubmed.ncbi.nlm.nih.gov/35216561/
- 34pubmed.ncbi.nlm.nih.gov/33005880/
- 35pubmed.ncbi.nlm.nih.gov/29407032/
- 36pubmed.ncbi.nlm.nih.gov/30724971/
- 37pubmed.ncbi.nlm.nih.gov/34008255/
- 40pubmed.ncbi.nlm.nih.gov/28536137/
- 41pubmed.ncbi.nlm.nih.gov/27363665/
- 42pubmed.ncbi.nlm.nih.gov/31034074/
- 43pubmed.ncbi.nlm.nih.gov/35513224/
- 44pubmed.ncbi.nlm.nih.gov/32160118/
- 45pubmed.ncbi.nlm.nih.gov/29907811/
- 46pubmed.ncbi.nlm.nih.gov/34122605/
- 47pubmed.ncbi.nlm.nih.gov/29121644/
- 48pubmed.ncbi.nlm.nih.gov/25523400/
- 49pubmed.ncbi.nlm.nih.gov/32701577/
- 50pubmed.ncbi.nlm.nih.gov/30662169/
- 52pubmed.ncbi.nlm.nih.gov/34702506/
- 53pubmed.ncbi.nlm.nih.gov/29494126/
- 54pubmed.ncbi.nlm.nih.gov/32449359/
- 55pubmed.ncbi.nlm.nih.gov/35934562/
- 56pubmed.ncbi.nlm.nih.gov/30878986/
- 57pubmed.ncbi.nlm.nih.gov/33722609/
- 58pubmed.ncbi.nlm.nih.gov/28804044/
- 59pubmed.ncbi.nlm.nih.gov/32700752/
- 60pubmed.ncbi.nlm.nih.gov/29938458/
- 61pubmed.ncbi.nlm.nih.gov/34307035/
- 65pubmed.ncbi.nlm.nih.gov/32399983/
- 66pubmed.ncbi.nlm.nih.gov/31096244/
- 67pubmed.ncbi.nlm.nih.gov/33934579/
- 68pubmed.ncbi.nlm.nih.gov/26782822/
- 69pubmed.ncbi.nlm.nih.gov/31309416/
- 70pubmed.ncbi.nlm.nih.gov/35221666/
- 71pubmed.ncbi.nlm.nih.gov/32664915/
- 75pubmed.ncbi.nlm.nih.gov/30708986/
- 33eur-lex.europa.eu/eli/reg/2014/536/oj
- 38strobe-statement.org/checklists/
- 39care-statement.org/checklist
- 51academia.edu/attachments/71990175/download_file?st=MTcxMjc5MjQ5OCw5LjEwMTY4MA%3D%3D
- 62ispeech.org/blog/ai-in-medical-writing-survey-2023
- 63database.ich.org/sites/default/files/E6_R2_Guideline.pdf
- 72simplyhired.com/blog/medical-transcription-cost-per-word
- 73bls.gov/oes/current/oes291094.htm
- 74bls.gov/oes/current/oes191000.htm
- 76bls.gov/oes/current/oes212012.htm
- 77bls.gov/oes/current/oes119081.htm
- 78bls.gov/oes/current/oes273011.htm
- 79bls.gov/oes/current/oes272011.htm
- 80iso.org/news/ref3020.html
- 81ncbi.nlm.nih.gov/pmc/articles/PMC6097506/
- 82emergingtechnews.com/translation-cost-per-word-report
- 83thebalancesmb.com/proofreading-prices-4059568